CN101569672A - Golden brain powder - Google Patents

Golden brain powder Download PDF

Info

Publication number
CN101569672A
CN101569672A CNA2008100277432A CN200810027743A CN101569672A CN 101569672 A CN101569672 A CN 101569672A CN A2008100277432 A CNA2008100277432 A CN A2008100277432A CN 200810027743 A CN200810027743 A CN 200810027743A CN 101569672 A CN101569672 A CN 101569672A
Authority
CN
China
Prior art keywords
powder
golden
brain powder
golden brain
grams
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2008100277432A
Other languages
Chinese (zh)
Inventor
潘诚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNA2008100277432A priority Critical patent/CN101569672A/en
Publication of CN101569672A publication Critical patent/CN101569672A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses golden brain powder which is characterized by comprising components of salvia miltiorrhiza, hawthorn, pseudo-ginseng and American ginseng which are ground into powder and mixed. The golden brain powder has the efficacy of invigorating blood circulation, resolving stagnation, tonifying qi and strengthening the body resistance can be used for treating apoplexy sequelae, hand and foot numbness, dizziness, hyperlipoidemia and the like. The price of the golden brain powder is lower, and one dose is only about RMB one yuan. Through clinical trials, the golden brain powder treats 600 patients of relevant diseases and has determined curative effect, effective rate of 85 percent and no side effect. Compared with Chinese patent medicine of the same class, the golden brain powder has low price and can be accepted by common people.

Description

Golden brain powder
Technical field
What the present invention relates to is a kind of golden brain powder, and this kind golden brain powder can be used for the treatment of apoplexy sequela, numb hand and foot, dizzy, hyperlipidemia etc.
Background technology
Treatment apoplexy sequela, numb hand and foot, dizzy, hyperlipidemia etc. are the difficult problems of medical circle, and such medicine all compare costliness usually.
Summary of the invention
The technical issues that need to address of the present invention provide a kind of golden brain powder, this kind golden brain powder treatment apoplexy sequela, numb hand and foot, dizzy, hyperlipidemia etc., and determined curative effect, cost is low, low price.
Technical solution problem of the present invention can be by taking following technical scheme:
Golden brain powder is characterized in that: component comprises Radix Salviae Miltiorrhizae, Fructus Crataegi, Radix Notoginseng, Radix Panacis Quinquefolii, and each component is developed into powder-mixed and forms.
According to Compendium of Material Medica record, Fructus Crataegi is called as only victory soup, can relieving dyspepsia, and again can activating blood circulation to dissipate blood stasis.Radix Salviae Miltiorrhizae has the title of " the same SIWU TANG of Radix Salviae Miltiorrhizae merit simply ", the effect of tool activating blood circulation to dissipate blood stasis.The merit of having of Radix Notoginseng silt, the florescence ginseng can QI invigorating be set upright.The selected medicine of this side all has no side effect, taking convenience, and our medicine is pulverized, and long-term clothes are taken 6 grams every day, compare with the similar Chinese patent medicine of now, and are cheap, can be accepted by ordinary people.This can activating blood circulation to dissipate blood stasis, and QI invigorating is set upright, and can be used for the treatment of apoplexy sequela, numb hand and foot, dizzy, hyperlipidemia etc.Price is lower, about the general monobasic of potion.Through patient people more than 600 of clinical experiment treatment related diseases kind, determined curative effect, effective percentage reaches 85%, and has no side effect.
Technical solution problem of the present invention can also solve by taking following corrective measure:
The weight proportion of each component is described Radix Salviae Miltiorrhizae 300 grams, described Fructus Crataegi 300 grams, described Radix Notoginseng 100 grams, described Radix Panacis Quinquefolii 300 grams.
The specific embodiment
Below in conjunction with specific embodiment the present invention is specifically described.
Golden brain powder, component comprise Radix Salviae Miltiorrhizae, Fructus Crataegi, Radix Notoginseng, Radix Panacis Quinquefolii, and each component is developed into powder-mixed and forms.The weight proportion of each component is described Radix Salviae Miltiorrhizae 300 grams, described Fructus Crataegi 300 grams, described Radix Notoginseng 100 grams, described Radix Panacis Quinquefolii 300 grams.
We treat patient people more than 600 of related diseases kind through clinical experiment, determined curative effect, and effective percentage reaches 85%, and has no side effect.
Case one, right side quadriplegia, dysphonia appear in 54 years old in Decembers, 2005 of Lee man, to examination in hospital is left cerebral infarction, hospitalization January, can hold up ten meters of crutch slope line numbers far away, the recuperation of being in afterwards, and take the medicine of microcirculation improvement, nutrition cranial nerve, but doing well,improving is little, and thinks that dizzy cardiopalmus is weak etc. uncomfortable.Withdraw Western medicine upon somebody's introduction, give gram golden brain side every days 6, take three months after, can free-hand walking more than 50 meter, after continue to take half a year, limb function recovers substantially, can be in and manage household affairs.
Case two, the beam woman occurs remaining unconscious the right side quadriplegia suddenly 64 years old in April, 2006, to examination in hospital is right cerebral hemorrhage, and hospitalization three months can be held up crutch slope row, the clothes Western medicine is 1 year after leaving hospital, and doing well,improving is little, withdraws Western medicine upon somebody's introduction, give golden brain side gram every days 6, take half a year, can free-hand broken row, after adhered to taking 1 year, limb function recovers substantially, takes care of oneself.
Fructus Crataegi is called as only victory soup, can relieving dyspepsia, and again can activating blood circulation to dissipate blood stasis.Radix Salviae Miltiorrhizae has the title of " the same SIWU TANG of Radix Salviae Miltiorrhizae merit simply ", the effect of tool activating blood circulation to dissipate blood stasis.The merit of having of Radix Notoginseng silt, the florescence ginseng can QI invigorating be set upright.The selected medicine of this side all has no side effect, taking convenience, and our medicine is pulverized, and long-term clothes are taken 6 grams every day, compare with the similar Chinese patent medicine of now, and are cheap, can be accepted by ordinary people.This can activating blood circulation to dissipate blood stasis, and QI invigorating is set upright, and can be used for the treatment of apoplexy sequela, numb hand and foot, dizzy, hyperlipidemia etc.Price is lower, about the general monobasic of potion.
Golden brain powder of the present invention can be used for the treatment of apoplexy sequela, numb hand and foot, dizzy, hyperlipidemia etc.

Claims (2)

1, golden brain powder is characterized in that: component comprises Radix Salviae Miltiorrhizae, Fructus Crataegi, Radix Notoginseng, Radix Panacis Quinquefolii, and each component is developed into powder-mixed and forms.
2, golden brain powder according to claim 1 is characterized in that: the weight proportion of each component is described Radix Salviae Miltiorrhizae 300 grams, described Fructus Crataegi 300 grams, described Radix Notoginseng 100 grams, described Radix Panacis Quinquefolii 300 grams.
CNA2008100277432A 2008-04-29 2008-04-29 Golden brain powder Pending CN101569672A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA2008100277432A CN101569672A (en) 2008-04-29 2008-04-29 Golden brain powder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2008100277432A CN101569672A (en) 2008-04-29 2008-04-29 Golden brain powder

Publications (1)

Publication Number Publication Date
CN101569672A true CN101569672A (en) 2009-11-04

Family

ID=41229242

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2008100277432A Pending CN101569672A (en) 2008-04-29 2008-04-29 Golden brain powder

Country Status (1)

Country Link
CN (1) CN101569672A (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102302684A (en) * 2011-09-23 2012-01-04 唐红芳 Radix notoginseng tablets for promoting blood circulation
CN102657688A (en) * 2012-06-06 2012-09-12 吴伟銮 Traditional Chinese medicine composition capable of preventing cardiovascular and cerebrovascular diseases and application thereof
CN104096084A (en) * 2014-06-27 2014-10-15 甘保明 Chinese herbal medicine composition capable of cleaning vascular walls
CN108743879A (en) * 2018-08-20 2018-11-06 河北东医生物科技有限公司 Antithrombotic youth element application in TCM
CN109260259A (en) * 2018-11-16 2019-01-25 广州神农生物技术有限公司 The preparation method and applications of Chinese medicine composition, Chinese medical extract
CN109288994A (en) * 2018-12-10 2019-02-01 李晓屏 A kind of hypolipemic ' Tongluowan ' prescription and its preparation process
CN113041293A (en) * 2021-04-19 2021-06-29 浏阳市中医医院 Traditional Chinese medicine composition for treating atherosclerosis
CN115336746A (en) * 2022-08-11 2022-11-15 南京电巢电气科技有限公司 Medicinal and edible composition for health preservation
CN115349632A (en) * 2022-08-11 2022-11-18 南京电巢电气科技有限公司 Medicinal and edible composition for health preservation

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102302684A (en) * 2011-09-23 2012-01-04 唐红芳 Radix notoginseng tablets for promoting blood circulation
CN102657688A (en) * 2012-06-06 2012-09-12 吴伟銮 Traditional Chinese medicine composition capable of preventing cardiovascular and cerebrovascular diseases and application thereof
CN104096084A (en) * 2014-06-27 2014-10-15 甘保明 Chinese herbal medicine composition capable of cleaning vascular walls
CN108743879A (en) * 2018-08-20 2018-11-06 河北东医生物科技有限公司 Antithrombotic youth element application in TCM
CN109260259A (en) * 2018-11-16 2019-01-25 广州神农生物技术有限公司 The preparation method and applications of Chinese medicine composition, Chinese medical extract
CN109260259B (en) * 2018-11-16 2021-09-17 广州神农生物技术有限公司 Traditional Chinese medicine composition, preparation method and application of traditional Chinese medicine extract
CN109288994A (en) * 2018-12-10 2019-02-01 李晓屏 A kind of hypolipemic ' Tongluowan ' prescription and its preparation process
CN113041293A (en) * 2021-04-19 2021-06-29 浏阳市中医医院 Traditional Chinese medicine composition for treating atherosclerosis
CN115336746A (en) * 2022-08-11 2022-11-15 南京电巢电气科技有限公司 Medicinal and edible composition for health preservation
CN115349632A (en) * 2022-08-11 2022-11-18 南京电巢电气科技有限公司 Medicinal and edible composition for health preservation

Similar Documents

Publication Publication Date Title
CN101569672A (en) Golden brain powder
CN100460008C (en) Chinese medicine composition for treating cancer
CN102688327B (en) Medicine composition of damp itch lotion and preparation method of medicine composition
CN101491646A (en) Traditional Chinese medicine preparation for neurologic impairment due to craniocerebral trauma and post-operation and preparation method thereof
CN1970045B (en) Externally applied Chinese medicine for treating cervical and lumbar spondylosis
CN102266488B (en) Medicament for treating leucoderma
CN105125674A (en) Medicament for treating hyperostosis and medicament-separated moxibustion of medicament
CN1326550C (en) Quick acting analgetic Chinese medicine liquid
CN100381155C (en) Medicine for treating mammary glands hyperplasia
CN101249184B (en) Medicine for treating osteoproliferation as well as its preparation method
CN101181383A (en) Medicine composition for treating apoplexy as well as preparation method
CN108066734A (en) A kind of Chinese mugwort soup moxibustion and preparation method
CN101411799B (en) Oral medicinal liquor for treating rheumatism and rheumatoid disease
CN103041192B (en) Bedsore paste
CN103656239B (en) A kind of Chinese drugs agentia for the treatment of wind syndrome of head and preparation method thereof
CN102008666B (en) Drug for treating lumbocrural pain
CN102309588A (en) Medicine for treating varicocele
CN102210846B (en) Medicament for treating dysmenorrhea
CN102526385B (en) Medicament for treating climacteric syndrome
CN101708300A (en) Medicinal composition for treating scrofula, hyperplasia of mammary glands and benign lymphadenoma
CN100374133C (en) Medicine for treating mammary gland hyperplasia
CN101856480B (en) Chinese medicament for treating myocardial infarction
CN102319390B (en) Medicament for treating chronic cholecystitis
CN102512527B (en) Traditional Chinese medicine composition for treating post-stroke depression
CN102389549B (en) Traditional Chinese medicinal composition for treating psoriasis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20091104